1Schmidt EB and Dyerberg J. Omega-3 fatty acids: current status in cardiovascular medicine. Drugs 1994; 47: 405–24.
2Schmidt EB. n-3 fatty acids and the risk of coronary heart disease. Dan. Med. Bull. 1997; 44: 1–22.
3Hepburn FN, Exler J and Weihrauch JL. Provisional tables on the content of omega-3 fatty acids and other fat components of selected foods. J. Am. Diet. Assoc. 1986; 86: 788–93.
4Soriguer F, Serns S Valverde E, et al. Lipid, protein, and calorie content of different Atlantic and Mediterranean fish, shellfish, and molluscs commonly eaten in the south of Spain. Eur. J. Epidemiol. 1997; 13: 451–63.
5Rapp JH, Connor WE, Lin DS Porter JM. Dietary eicosapentaenoic acid and docosahexaenoic acid from fish oil. Their incorporation into advanced human atherosclerotic plaques. Arterioscler. Thromb. 1991; 11: 903–11.
6Fuster V, Badimon L, Badimon JJ Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 1992; 326: 310–18.
7Davies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation 1996; 94: 2013–20.
8Mulvad G, Pedersen HS, Jul E, et al. Atherosclerosis in Greenland natives. An autopsy study. Poster presented at the Ninth International Congress on Circumpolar Health, Reykjavik, Iceland, 20–25 June 1993.
9Newman WP III, Propst MT, Middaugh JP. Atherosclerosis in Alaska natives and non-natives. Lancet 1993; 341: 1056–7.
10Hamazaki T, Urakaze M, Sawazaki S, Yamazaki K, Taki H, Yano S. Comparison of pulse wave velocity of the aorta between inhabitants of fishing and farming villages in Japan. Atherosclerosis 1988; 73: 157–60.
11Soei LK, Lamers JMJ, Sassen LMA, et al. Fish oil: a modulator of experimental atherosclerosis in animals. In: Kristensen SD, Schmidt EB, De Caterina R, Endres S, eds. n-3 Fatty Acids: Prevention and Treatment of Vascular Disease. Springer Verlag: Bi & Gi Publishers, 1995; 55–75.
12Hornstra G. The significance of fish and and fish-oil enriched food for prevention and therapy of cardiovascular disease. In: Vergroesen A, Crawford M, eds. The Role of Fats in Human Nutrition. London: Academic Press, 1989; 152–235.
13Lam JYT, Badimon JJ, Ellefson RD, Fuster V, Chesebro JH. Cod liver oil alters platelet–arterial wall response to injury in pigs. Circ. Res. 1992; 71: 769–75.
14Harker LA, Kelly AB, Hanson SR, et al. Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation 1993; 87: 1017–29.
15Kim D, Schmee J and Baker JE, et al. Dietary fish oil reduces microthrombi over atherosclerotic lesions in hyperlipidemic swine even in the absence of plasma cholesterol reduction. Exp. Mol. Pathol. 1993; 59: 122–35.
16National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (ATP II). Circulation 1994; 89, 1329–445.
17Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Eur. Heart J. 1998; 19: 1434–503.
18Schmidt EB, Kristensen SD, De Caterina R, Illingworth DR. The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 1993; 103: 107–21.
19Harris WS. n-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 1996; 31: 243–52.
20Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? Circulation 1993; 88: 523–33.
21Toft I, Bønaa KH, Ingebretsen OC, Nordøy A and Jenssen T. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertention. Ann. Intern. Med. 1995; 123: 911–18.
22Ernst E. Effects of n-3 fatty acids on blood rheology. J. Intern. Med. 1989; 225: (Suppl. 1), 129–32.
23Goode GK, Garcia S, Heagerty AM. Dietary supplementation with marine fish oil improves. in vitro small artery endothelial function in hypercholesterolemic patients. Circulation 1997; 96: 2802–7.
24Rodriquez BL, Sharp DS, Abbott RD, et al. . Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers. Circulation 1996; 94: 952–6.
25Shahar E, Folsom AR, Melnick SL, et al. . Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N. Engl. J. Med. 1994; 331: 228–33.
26Bjerregaard P, Dyerberg J. Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. Int. J. Epidemiol. 1988; 17: 514–19.
27Kagawa Y, Nishizawa M and Suzuki M, et al. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J. Nutr. Sci. Vitaminol. 1982; 28: 441–53.
28Kromhout D, Bosschieter EB, Coulander CDL. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N. Engl. J. Med. 1985; 312: 1205–9.
29Kromhout D, Feskens EJM, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int. J. Epidemiol. 1995; 24: 340–5.
30Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N. Engl. J. Med. 1997; 336: 1046–53.
31Norell SE, Ahlbom A, Feychting M, et al. Fish consumption and mortality from heart disease. BMJ 1986; 293, 426.
32Gramenzi A, Gentile A, Fasoli M, et al. Association between certain foods and risk of acute myocardial infarction in women. BMJ 1990; 300: 771–3.
33Dolecek TA, Grandits G. Dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial (MRFIT). World Rev. Nutr. Diet. 1991; 66: 205–16.
34Feskens EJM, Bowles CH, Kromhout D. Association between fish intake and coronary heart disease mortality. Diabetes Care 1993; 16: 1029–34.
35Morris MC, Manson JAE, Rosner B, Buring JE, Willett WC, Hennekens CH. Fish consumption and cardiovascular disease in the Physician's Health Study: a prospective study. Am. J. Epidemiol. 1995; 142: 166–75.
36Crombie IK, McLoone P and Smith WCS, et al. International differences in coronary heart disease mortality and consumption of fish and other foodstuffs. Eur. Heart J. 1987; 8: 560–3.
37Vollset SE, Heuch I, Bjelke E. Fish consumption and coronary heart disease. N. Engl. J. Med. 1985; 313: 820–1.
38Lapidus L, Andersson H, Bengtsson C, et al. Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am. J. Clin. Nutr. 1986; 44: 444–8.
39Simonsen T, Vårtun Å and Lyngmo V, et al. Coronary heart disease, serum lipids, platelets and dietary fish in two communities in northern Norway. Acta Med. Scand. 1987; 222: 237–45.
40Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL and Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N. Engl. J. Med. 1995; 332: 977–82.
41Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA 1998; 279: 23–8.
42Saynor R, Verel D, Gillott T. The long term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis 1984; 50: 3–10.
43Kristensen SD, Schmidt EB, Andersen HR, Dyerberg J. Fish oil in angina pectoris. Atherosclerosis 1987; 64: 13–19.
44Burr ML, Fehily AM, Gilbert JF. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 1989; 2, 757–61.
45De Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454–9.
46Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival – 4. Cardiovasc. Drugs Ther. 1997; 11: 485–91.
47Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch. Intern. Med. 1993; 153: 1595–601.
48Cairns JA, Gill J and Morton B, et al. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. Circulation 1994; 94, 1553–60.
49Leaf A, Jorgensen MB, Jacobs AK, et al. Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994; 90: 2248–57.
50Johansen O, Brekke M, Seljeflot I, Abdelnoor M, Arnesen H. n-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. J. Am. Coll. Cardiol. 1999; 33: 1619–26.
51Roy L, Meyer F, Gingras L and Auger L. A double-blind randomized controlled study comparing the efficacy of fish oil and low dose ASA to prevent coronary saphenous vein graft obstruction after CABG. Circulation 1991; 84(Suppl. II), II–285.
52Eritsland J, Arnesen H, Grønseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am. J. Cardiol. 1996; 77: 31–6.
53Charnock JS, McLennan PL and Abeywardena MY. Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol. Cell. Biochem. 1992; 116: 19–25.
54McLennan PL. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am. J. Clin. Nutr. 1993; 57: 207–12.
55Nair SSD, Leitch JW, Falconer J, Garg ML. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J. Nutr. 1997; 127: 383–93.
56Hallaq H, Smith TW, Leaf A. Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc. Natl. Acad. Sci. USA 1992; 89: 1760–4.
57Kang JX, Leaf A. Prevention and termination of beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochem. Biophys. Res. Commun. 1995; 208: 629–36.
58Garratt JC, McEnvoy MP, Owen DG. Blockade of two voltage-dependent potassium channels, mKv 1.1 and mKv 1.2, by docosahexaenoic acid. Eur. J. Pharmacol. 1996; 14, 393–6.
59Kang JX, Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids. Recent studies. Circulation 1996; 94: 1774–80.
60Luostarinen R, Boberg M, Saldeen T. Fatty acid composition in total phospholipids of human coronary arteries in sudden cardiac death. Atherosclerosis 1993; 99: 187–93.
61Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274: 1363–7.
62Christensen JH, Gustenhoff P, Ejlersen E, et al. n-3 fatty acids and ventricular extrasystoles in patients with ventricular tachyarrhythmias. Nutr. Res. 1995; 15, 1–8.
63Sellmayer A, Witzgall H, Lorenz RL, Weber PC. Effects of dietary fish oil on ventricular premature complexes. Am. J. Cardiol. 1995; 76: 974–7.
64Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93, 1043–65.
65Christensen JH, Gustenhoff P and Korup E, et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 1996; 312: 677–8.
66Christensen JH, Korup E and Aarøe J, et al. Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am. J. Cardiol. 1997; 79: 1670–3.
67Christensen JH, Aarøe J, Knudsen N, et al. Heart rate variability and n-3 fatty acids in patients with chronic renal failure – a pilot study. Clin. Nephrol. 1998; 49: 102–6.
68Christensen JH, Christensen MS, Dyerberg J, Schmidt EB. Fatty acids in blood cell membranes is related to heart rate variability. A dose–response study with n-3 fatty acids. Am. J. Clin. Nutr. 1999; 70: 331–7.
69Seidelin KN, Myrup B, Fischer-Hansen B. n-3 fatty acids in adipose tissue and coronary artery disease are inversely related. Am. J. Clin. Nutr. 1992; 55: 1117–19.
70Sacks FM, Stone PH, Gibson M, Silverman DI, Rosner B, Pasternak RC. Controlled trial of fish oil for regression of human coronary atherosclerosis. J. Am. Coll. Cardiol. 1995; 25: 1492–8.
71Von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 1999; 130: 554–62.
72Salonen JT, Seppänen K, Nyyssönen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 1995; 91: 645–55.
73Witzkum JL and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 1991; 88: 1785–92.
74Suzukawa M, Abbey M, Howe PR, Nestel PJ. Effect of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res. 1995; 36: 473–84.
75Brude IR, Drevon CA, Hjermann I, et al. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with ω-3 fatty acids and antioxidants. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2576–88.
76Smith P, Arnesen H, Opstad T, et al. Influence of highly concentrated n-3 fatty acids on serum lipids and hemostatic variables in survivors of myocardial infarction receiving either oral anticoagulants or matching placebo. Thromb. Res. 1989; 53: 467–74.
77Bender NK, Kraynak MA, Chiquette E, Linn WD, Clark GM and Bussey HI. Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy. J. Thromb. Thrombolys. 1998; 5, 257–61.
78Schmidt EB, Møller JM, Svaneborg N and Dyerberg J. Safety aspects of fish oils. Drug Invest. 1994; 7, 215–20.
79Sirtori CR, Paoletti R, Mancini M, et al. n-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Am. J. Clin. Nutr. 1997; 65: 1874–81.
80 Friedberg, Janssen MJFM, Heine RJ, Grobbee DE. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 1998; 21, 494–500.
81Weber PC. Clinical studies on the effect of n-3 fatty acids on cells and eicosanoids in the cardiovascular system. J. Intern. Med. 1989; 225(Suppl. 1), 61–8.
82Skuladottir GV, Gudmundsdottir S, Olafsson GB, et al. Plasma fatty acids and lipids in two separate, but genetically comparable, Icelandic populations. Lipids 1995; 30: 649–55.
83Newton IS. Global food fortification perspectives of long-chained omega 3 fatty acids. In: Simopoulos AP, ed. The Return of Omega 3 Fatty Acids into the Food Supply. I. Land-based Animal Food Products and their Health Effects. Basel: Karger, 1998; 199–209.
84Health and Welfare Canada. Nutrition Recommendations. Ottawa: Minister of Supply and Services, 1990.
85 British Nutritional Foundation. Unsaturated Fatty Acids: Nutritional and Physiological Significance. Report of the British Nutritional Foundation's Task Force. BNF, 1992.
86Norris RM. Fatality outside hospital from acute coronary events in three British health districts, 1994–5. BMJ 1998; 316: 1065–70.
87Barron HV, Viskin S. Autonomic markers and prediction of cardiac death after myocardial infarction. Lancet 1998; 351: 461–2.
88De Deckere EAM, Korver O, Verscheuren PM, Katan MB. Health aspects of fish and n-3 polyunsaturated fatty acids from plant and marine origin. Eur. J. Clin. Invest. 1998; 52: 749–53.